Esperion Therapeutics (ESPR) Q1 2026 Earnings

10MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.21
-0.06
0.09
0.24

Details

Expected EPS
0.243333
Actual EPS
0.22
Surprise EPS
-0.02
Surprise Percent
+9.59%

Description

Esperion Therapeutics (ESPR) has reported earnings of 0.22 per share for Q1 2026.

0 Comments

Share your thoughts